Sangon Biotech
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A major Chinese provider of research reagents, sequencing services, and diagnostic products for genomics and proteomics applications.
Technology Platform
Integrated platform for DNA synthesis, oligonucleotide production, protein expression, antibody development, and large-scale sequencing services to support life science research and diagnostics.
Opportunities
Growth is driven by expansion of China's biopharma R&D sector, increased demand for research tools in genomics and proteomics, and strategic moves into diagnostic kit manufacturing.
Risk Factors
Faces intense competition from global giants and local firms, operates in a fragmented and price-sensitive market for many reagents, and is exposed to supply chain volatility for raw materials.
Competitive Landscape
Competes with global reagent suppliers (Thermo Fisher, Merck) and Chinese peers (BGI-related entities, Vazyme) on product breadth, price, and local service; differentiation lies in its extensive catalog and integrated service model within China.